Royal Philips Stock CBOE EUROPE EQUITIES
Equities
NL0000009538
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
06-28 | PHILIPS NV : JP Morgan reiterates its Neutral rating | ZD |
06-27 | Chinese-owned chipmaker Nexperia invests $200 mln in European expansion | RE |
Sales 2024 * | 18.71B 20.04B 27.4B | Sales 2025 * | 19.68B 21.08B 28.83B | Capitalization | 22B 23.57B 32.23B |
---|---|---|---|---|---|
Net income 2024 * | 193M 207M 283M | Net income 2025 * | 1.17B 1.25B 1.71B | EV / Sales 2024 * | 1.44 x |
Net Debt 2024 * | 4.87B 5.22B 7.13B | Net Debt 2025 * | 4.56B 4.89B 6.69B | EV / Sales 2025 * | 1.35 x |
P/E ratio 2024 * |
118
x | P/E ratio 2025 * |
21.3
x | Employees | - |
Yield 2024 * |
3.61% | Yield 2025 * |
3.76% | Free-Float | 83.42% |
Latest transcript on Royal Philips
Managers | Title | Age | Since |
---|---|---|---|
Roy Jakobs
CEO | Chief Executive Officer | 50 | 09-12-31 |
Director of Finance/CFO | 62 | 86-12-31 | |
Shez Partovi
CTO | Chief Tech/Sci/R&D Officer | 57 | 21-03-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 14-12-31 |
Sanjay Poonen
BRD | Director/Board Member | 55 | 21-12-31 |
Director/Board Member | 68 | 21-04-30 |
1st Jan change | Capi. | |
---|---|---|
+8.00% | 185B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 64.32B | |
+21.14% | 55.66B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B | |
+11.28% | 28.12B |